TrialNet: Pathway to Prevention of Type 1 Diabetes
Principal Investigator: Dr. Katie Pundyk
TrialNet is a research group dedicated to the study, prevention, and early treatment of type 1 diabetes. Type 1 diabetes is now understood as a disease that develops over time in stages. Stage 1 starts with the appearance of two or more autoantibodies. This is followed by Stage 2, which is the development of abnormal blood glucose levels. Stage 3 is the diagnosis of type 1 diabetes. This study will help us learn more about how type 1 diabetes occurs and provides monitoring to individuals at risk.